BIOL logo

BIOLASE (BIOL) Free Cash Flow

Annual FCF

-$15.40 M
+$15.09 M+49.48%

December 31, 2023


Summary


Performance

BIOL Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLcash flowmetrics:

Quarterly FCF

-$4.51 M
-$3.75 M-492.90%

September 30, 2024


Summary


Performance

BIOL Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLcash flowmetrics:

TTM FCF

-$13.68 M
-$1.74 M-14.59%

September 30, 2024


Summary


Performance

BIOL TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBIOLcash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

BIOL Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+49.5%-62.9%+28.0%
3 y3 years-19.5%-62.9%+28.0%
5 y5 years-4.7%-62.9%+28.0%

BIOL Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+97.9%+492.9%+104.4%+14.6%+122.9%
5 y5-year+19.5%+97.9%+492.9%+104.4%+14.6%+122.9%
alltimeall time-354.2%+97.9%-182.1%+126.2%-325.8%+122.9%

BIOLASE Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.51 M(+492.9%)
-$13.68 M(+14.6%)
Jun 2024
-
-$761.00 K(-87.2%)
-$11.94 M(-20.9%)
Mar 2024
-
-$5.94 M(+140.6%)
-$15.10 M(-2.0%)
Dec 2023
-$15.40 M(-49.5%)
-$2.47 M(-10.9%)
-$15.40 M(-18.9%)
Sep 2023
-
-$2.77 M(-29.3%)
-$18.99 M(-25.4%)
Jun 2023
-
-$3.92 M(-37.2%)
-$25.44 M(-10.4%)
Mar 2023
-
-$6.25 M(+3.2%)
-$28.41 M(-6.8%)
Dec 2022
-$30.49 M(+75.0%)
-$6.05 M(-34.4%)
-$30.49 M(+9.5%)
Sep 2022
-
-$9.22 M(+34.0%)
-$27.85 M(+24.8%)
Jun 2022
-
-$6.89 M(-17.3%)
-$22.31 M(+16.0%)
Mar 2022
-
-$8.32 M(+143.8%)
-$19.23 M(+10.4%)
Dec 2021
-$17.42 M(+35.1%)
-$3.42 M(-7.3%)
-$17.42 M(+13.3%)
Sep 2021
-
-$3.68 M(-3.4%)
-$15.37 M(+11.4%)
Jun 2021
-
-$3.81 M(-41.4%)
-$13.79 M(-9.6%)
Mar 2021
-
-$6.51 M(+376.4%)
-$15.26 M(+18.3%)
Dec 2020
-$12.89 M(-0.5%)
-$1.37 M(-35.1%)
-$12.89 M(-20.7%)
Sep 2020
-
-$2.10 M(-60.1%)
-$16.27 M(+4.1%)
Jun 2020
-
-$5.28 M(+27.4%)
-$15.62 M(+29.6%)
Mar 2020
-
-$4.14 M(-12.6%)
-$12.05 M(-6.9%)
Dec 2019
-$12.95 M(-11.9%)
-$4.74 M(+224.7%)
-$12.95 M(+6.0%)
Sep 2019
-
-$1.46 M(-14.6%)
-$12.22 M(-6.0%)
Jun 2019
-
-$1.71 M(-66.1%)
-$13.00 M(-12.6%)
Mar 2019
-
-$5.04 M(+25.9%)
-$14.88 M(+1.2%)
Dec 2018
-$14.71 M(-23.2%)
-$4.00 M(+78.4%)
-$14.71 M(-1.2%)
Sep 2018
-
-$2.25 M(-37.5%)
-$14.88 M(-7.4%)
Jun 2018
-
-$3.59 M(-26.2%)
-$16.07 M(-14.0%)
Mar 2018
-
-$4.86 M(+16.4%)
-$18.69 M(-2.4%)
Dec 2017
-$19.16 M(+59.5%)
-$4.18 M(+21.6%)
-$19.16 M(+3.7%)
Sep 2017
-
-$3.44 M(-44.7%)
-$18.48 M(+10.2%)
Jun 2017
-
-$6.21 M(+16.6%)
-$16.78 M(+37.2%)
Mar 2017
-
-$5.33 M(+52.2%)
-$12.22 M(+1.8%)
Dec 2016
-$12.01 M(-38.6%)
-$3.50 M(+102.3%)
-$12.01 M(+1.1%)
Sep 2016
-
-$1.73 M(+4.2%)
-$11.88 M(-20.2%)
Jun 2016
-
-$1.66 M(-67.5%)
-$14.88 M(-12.8%)
Mar 2016
-
-$5.12 M(+51.9%)
-$17.06 M(-12.8%)
Dec 2015
-$19.57 M(+19.4%)
-$3.37 M(-28.9%)
-$19.57 M(-11.6%)
Sep 2015
-
-$4.74 M(+23.2%)
-$22.14 M(-10.9%)
Jun 2015
-
-$3.84 M(-49.6%)
-$24.85 M(+17.5%)
Mar 2015
-
-$7.63 M(+28.6%)
-$21.15 M(+28.9%)
Dec 2014
-$16.40 M(+64.3%)
-$5.93 M(-20.3%)
-$16.40 M(+27.3%)
Sep 2014
-
-$7.44 M(+5141.5%)
-$12.88 M(+70.2%)
Jun 2014
-
-$142.00 K(-95.1%)
-$7.57 M(-23.5%)
Mar 2014
-
-$2.88 M(+19.5%)
-$9.89 M(-0.9%)
Dec 2013
-$9.98 M(+301.5%)
-$2.41 M(+13.2%)
-$9.98 M(+71.7%)
Sep 2013
-
-$2.13 M(-13.5%)
-$5.81 M(+38.7%)
Jun 2013
-
-$2.46 M(-17.0%)
-$4.19 M(-8.9%)
Mar 2013
-
-$2.97 M(-269.2%)
-$4.60 M(+85.0%)
Dec 2012
-$2.49 M(-81.9%)
$1.76 M(-443.6%)
-$2.49 M(-61.1%)
Sep 2012
-
-$511.00 K(-82.2%)
-$6.39 M(-37.4%)
Jun 2012
-
-$2.87 M(+234.3%)
-$10.22 M(+7.3%)
Mar 2012
-
-$859.00 K(-60.1%)
-$9.53 M(-30.7%)
Dec 2011
-$13.75 M(+239.5%)
-$2.15 M(-50.4%)
-$13.75 M(+15.9%)
Sep 2011
-
-$4.34 M(+99.1%)
-$11.86 M(+40.1%)
Jun 2011
-
-$2.18 M(-57.1%)
-$8.46 M(-12.3%)
Mar 2011
-
-$5.08 M(+1839.7%)
-$9.65 M(+138.3%)
Dec 2010
-$4.05 M(+34.1%)
-$262.00 K(-72.1%)
-$4.05 M(-13.7%)
Sep 2010
-
-$940.00 K(-72.0%)
-$4.69 M(+31.9%)
Jun 2010
-
-$3.36 M(-751.7%)
-$3.56 M(-377.6%)
Mar 2010
-
$516.00 K(-157.1%)
$1.28 M(-142.4%)
Dec 2009
-$3.02 M
-$904.00 K(-563.6%)
-$3.02 M(-57.8%)
Sep 2009
-
$195.00 K(-86.8%)
-$7.16 M(-34.0%)
Jun 2009
-
$1.47 M(-138.9%)
-$10.86 M(+9.3%)
DateAnnualQuarterlyTTM
Mar 2009
-
-$3.79 M(-24.9%)
-$9.93 M(+80.5%)
Dec 2008
-$5.50 M(+32.7%)
-$5.04 M(+44.0%)
-$5.50 M(+1228.7%)
Sep 2008
-
-$3.50 M(-245.8%)
-$414.00 K(-116.5%)
Jun 2008
-
$2.40 M(+274.7%)
$2.52 M(-285.7%)
Mar 2008
-
$641.00 K(+1356.8%)
-$1.35 M(-67.3%)
Dec 2007
-$4.14 M(+118.1%)
$44.00 K(-107.7%)
-$4.14 M(-40.8%)
Sep 2007
-
-$571.00 K(-61.1%)
-$7.00 M(+38.5%)
Jun 2007
-
-$1.47 M(-31.6%)
-$5.06 M(+216.6%)
Mar 2007
-
-$2.15 M(-23.7%)
-$1.60 M(-15.9%)
Dec 2006
-$1.90 M(-90.0%)
-$2.82 M(-304.5%)
-$1.90 M(-262.0%)
Sep 2006
-
$1.38 M(-30.8%)
$1.17 M(-119.1%)
Jun 2006
-
$1.99 M(-181.2%)
-$6.13 M(-45.1%)
Mar 2006
-
-$2.45 M(-1053.7%)
-$11.16 M(-41.0%)
Dec 2005
-$18.91 M(+530.1%)
$257.00 K(-104.3%)
-$18.91 M(-9.2%)
Sep 2005
-
-$5.92 M(+94.7%)
-$20.82 M(+34.4%)
Jun 2005
-
-$3.04 M(-70.2%)
-$15.50 M(+23.1%)
Mar 2005
-
-$10.20 M(+517.7%)
-$12.59 M(+319.4%)
Dec 2004
-$3.00 M(-149.5%)
-$1.65 M(+176.7%)
-$3.00 M(-172.4%)
Sep 2004
-
-$597.00 K(+332.6%)
$4.15 M(+0.7%)
Jun 2004
-
-$138.00 K(-77.6%)
$4.12 M(-20.6%)
Mar 2004
-
-$615.00 K(-111.2%)
$5.19 M(-14.4%)
Dec 2003
$6.06 M(<-9900.0%)
$5.50 M(-981.1%)
$6.06 M(+478.1%)
Sep 2003
-
-$624.00 K(-167.2%)
$1.05 M(-48.2%)
Jun 2003
-
$928.00 K(+261.1%)
$2.02 M(+70.8%)
Mar 2003
-
$257.00 K(-47.2%)
$1.18 M(<-9900.0%)
Dec 2002
-$1000.00(-99.9%)
$487.00 K(+39.1%)
-$1000.00(-99.7%)
Sep 2002
-
$350.00 K(+288.9%)
-$368.00 K(-79.9%)
Jun 2002
-
$90.00 K(-109.7%)
-$1.83 M(+32.4%)
Mar 2002
-
-$928.00 K(-873.3%)
-$1.38 M(+12.3%)
Dec 2001
-$1.23 M(-74.6%)
$120.00 K(-110.8%)
-$1.23 M(+68.1%)
Sep 2001
-
-$1.11 M(-306.6%)
-$731.80 K(-58.9%)
Jun 2001
-
$537.40 K(-169.2%)
-$1.78 M(-58.3%)
Mar 2001
-
-$777.10 K(-225.7%)
-$4.27 M(-12.0%)
Dec 2000
-$4.85 M(+146.6%)
$618.20 K(-128.6%)
-$4.85 M(-14.4%)
Sep 2000
-
-$2.16 M(+10.7%)
-$5.66 M(+45.0%)
Jun 2000
-
-$1.95 M(+43.5%)
-$3.90 M(+19.9%)
Mar 2000
-
-$1.36 M(+588.5%)
-$3.26 M(+71.6%)
Dec 1999
-$1.97 M(-61.5%)
-$197.30 K(-50.7%)
-$1.90 M(-24.1%)
Sep 1999
-
-$400.00 K(-69.2%)
-$2.50 M(+56.3%)
Jun 1999
-
-$1.30 M(<-9900.0%)
-$1.60 M(-54.3%)
Mar 1999
-
$0.00(-100.0%)
-$3.50 M(-31.4%)
Dec 1998
-$5.10 M(+24.4%)
-$800.00 K(-260.0%)
-$5.10 M(-13.6%)
Sep 1998
-
$500.00 K(-115.6%)
-$5.90 M(-14.5%)
Jun 1998
-
-$3.20 M(+100.0%)
-$6.90 M(+43.8%)
Mar 1998
-
-$1.60 M(0.0%)
-$4.80 M(+17.1%)
Dec 1997
-$4.10 M(+78.3%)
-$1.60 M(+220.0%)
-$4.10 M(+28.1%)
Sep 1997
-
-$500.00 K(-54.5%)
-$3.20 M(0.0%)
Jun 1997
-
-$1.10 M(+22.2%)
-$3.20 M(+23.1%)
Mar 1997
-
-$900.00 K(+28.6%)
-$2.60 M(+18.2%)
Dec 1996
-$2.30 M(+35.3%)
-$700.00 K(+40.0%)
-$2.20 M(+22.2%)
Sep 1996
-
-$500.00 K(0.0%)
-$1.80 M(+5.9%)
Jun 1996
-
-$500.00 K(0.0%)
-$1.70 M(+13.3%)
Mar 1996
-
-$500.00 K(+66.7%)
-$1.50 M(-11.8%)
Dec 1995
-$1.70 M(-37.0%)
-$300.00 K(-25.0%)
-$1.70 M(+21.4%)
Sep 1995
-
-$400.00 K(+33.3%)
-$1.40 M(+40.0%)
Jun 1995
-
-$300.00 K(-57.1%)
-$1.00 M(+42.9%)
Mar 1995
-
-$700.00 K(-22.2%)
-$700.00 K(-88.5%)
Dec 1994
-$2.70 M(-55.7%)
-
-
Dec 1993
-$6.10 M(-1.6%)
-$900.00 K(-50.0%)
-$6.10 M(+17.3%)
Sep 1993
-
-$1.80 M(+12.5%)
-$5.20 M(+52.9%)
Jun 1993
-
-$1.60 M(-11.1%)
-$3.40 M(+88.9%)
Mar 1993
-
-$1.80 M
-$1.80 M
Dec 1992
-$6.20 M
-
-

FAQ

  • What is BIOLASE annual free cash flow?
  • What is the all time high annual FCF for BIOLASE?
  • What is BIOLASE annual FCF year-on-year change?
  • What is BIOLASE quarterly free cash flow?
  • What is the all time high quarterly FCF for BIOLASE?
  • What is BIOLASE quarterly FCF year-on-year change?
  • What is BIOLASE TTM free cash flow?
  • What is the all time high TTM FCF for BIOLASE?
  • What is BIOLASE TTM FCF year-on-year change?

What is BIOLASE annual free cash flow?

The current annual FCF of BIOL is -$15.40 M

What is the all time high annual FCF for BIOLASE?

BIOLASE all-time high annual free cash flow is $6.06 M

What is BIOLASE annual FCF year-on-year change?

Over the past year, BIOL annual free cash flow has changed by +$15.09 M (+49.48%)

What is BIOLASE quarterly free cash flow?

The current quarterly FCF of BIOL is -$4.51 M

What is the all time high quarterly FCF for BIOLASE?

BIOLASE all-time high quarterly free cash flow is $5.50 M

What is BIOLASE quarterly FCF year-on-year change?

Over the past year, BIOL quarterly free cash flow has changed by -$1.74 M (-62.89%)

What is BIOLASE TTM free cash flow?

The current TTM FCF of BIOL is -$13.68 M

What is the all time high TTM FCF for BIOLASE?

BIOLASE all-time high TTM free cash flow is $6.06 M

What is BIOLASE TTM FCF year-on-year change?

Over the past year, BIOL TTM free cash flow has changed by +$5.31 M (+27.96%)